RESEARCH TRIANGLE PARK, N.C., April 20, 2010 /PRNewswire via COMTEX/ --Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) held its annual meeting of stockholders today in Chapel Hill, N.C.

During the meeting, the stockholders elected Paul N. Clark and Kenneth J. Martin as Class I Directors to serve on the company's Board of Directors for three-year terms ending in 2013. Stockholders also ratified the appointment of PricewaterhouseCoopers LLP as the company's independent public accounting firm for the fiscal year ending December 31, 2010.

A replay of the meeting will be available beginning at 12 p.m. EDT and will remain accessible until April 27, 2010, by dialing 1-888-286-8010 (domestic) or 1-617-801-6888 (international). The international pass code number is 74341672. The webcast of the meeting call will be archived on the Investor Relations section of http://www.talecris.com.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com.

SOURCE Talecris Biotherapeutics, Inc.